万方数据知识服务平台
应用市场
我的应用
会员HOT
万方期刊
×

点击收藏,不怕下次找不到~

@万方数据
会员HOT

期刊专题

Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses

引用
The novel coronavirus,2019-nCov (named as SARS-CoV-2 by ICTV Coronaviridae Study Group on February 12,2020),causes severe respiratory illness1 and has been spreading around the world rapidly.2 As of February 14,2020,there are over 64,000 confirmed cases with 1,384 deaths.This raises an urgent need for an effective treatment of the deadly disease.However,current antiviral drugs have limited effects on 2019-nCov (SARS-CoV-2).Although Gilead's NUC (nucleoside) inhibitor,which previously failed to treat Ebola,seemed to benefit a 2019-nCov (SARS-CoV-2) patient in Washington,USA,it remains unknown whether the drug will be effective against the virus in other patients,who may have been infected by different variants of the virus.Our analysis of 2019-nCov (SARS-CoV-2) RNA genome from 19 patients in China,USA and Australia reveals that these viruses have differences in sequence (Fig.1a).These differences are mostly single nucleotide variations.Fig.1b shows an example of single nucleotide variations that result in changes in amino acids 62 and 84 of ORF8 of 2019-nCov (SARS-CoV-2),a polypeptide implicated in driving coronavirus transition from bat to human.3 The evidence from patient samples suggests that 2019-nCov (SARS-CoV-2) is actively acquiring new mutations that may enable it to escape antiviral drugs.This raises a serious challenge to the development of conventional drugs and of vaccines.The same limitations apply to other deadly RNA viruses such as SARS or MERS.

30

2020-06-15(万方平台首次上网日期,不代表论文的发表时间)

共2页

189-190

相关文献
评论
暂无封面信息
查看本期封面目录

细胞研究(英文版)

1001-0602

31-1568

30

2020,30(3)

相关作者
相关机构

专业内容知识聚合服务平台

国家重点研发计划“现代服务业共性关键技术研发及应用示范”重点专项“4.8专业内容知识聚合服务技术研发与创新服务示范”

国家重点研发计划资助 课题编号:2019YFB1406304
National Key R&D Program of China Grant No. 2019YFB1406304

©天津万方数据有限公司 津ICP备20003920号-1

信息网络传播视听节目许可证 许可证号:0108284

网络出版服务许可证:(总)网出证(京)字096号

违法和不良信息举报电话:4000115888    举报邮箱:problem@wanfangdata.com.cn

举报专区:https://www.12377.cn/

客服邮箱:op@wanfangdata.com.cn